ISSN:
1573-2592
Keywords:
Graft-versus-host disease
;
monoclonal anti-T-cell antibodies
;
allogeneic marrow transplantation
;
prevention
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Protection of mice against graft-versus-host disease (GVHD) can be accomplished by incubating donor marrow with anti-T-cell antisera or with an anti-Thy-1 monoclonal antibody. Incubation of donor marrow with a single anti-T-cell monoclonal antibody, however, does not prevent GVHD in humans. Therefore, we carried out a clinical trial to determine the effect of treatment of donor marrow with a combination of eight anti-T-cell antibodies in the absence of complement. The nine patients were genotypically HLA identical with their donors and received methotrexate postgrafting. Prompt engraftment occurred in eight patients. Of six patients surviving at least 40 days with sustained engraftment, three had severe (grade III or IV) GVHD. Thus, there is no evidence that treatment of donor marrow with murine anti-T-cell monoclonal antibodies as described here can prevent GVHD.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00915282
Permalink